A detailed history of Syntax Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Syntax Advisors, LLC holds 6,764 shares of PFE stock, worth $179,651. This represents 0.39% of its overall portfolio holdings.

Number of Shares
6,764
Previous 5,906 14.53%
Holding current value
$179,651
Previous $216,000 3.7%
% of portfolio
0.39%
Previous 0.33%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $27,533 - $32,183
858 Added 14.53%
6,764 $224,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $6,357 - $7,355
-176 Reduced 2.89%
5,906 $216,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $55,618 - $72,407
1,412 Added 30.24%
6,082 $248,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $29,183 - $38,095
-699 Reduced 13.02%
4,670 $239,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $24,330 - $29,701
556 Added 11.55%
5,369 $235,000
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $11,399 - $13,516
245 Added 5.36%
4,813 $252,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $16,287 - $20,181
-356 Reduced 7.23%
4,568 $236,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $203,459 - $301,595
4,924 New
4,924 $291,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Syntax Advisors, LLC Portfolio

Follow Syntax Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntax Advisors, LLC with notifications on news.